Opitz GBBB syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2745OMIM:300000Q87.8
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Opitz GBBB syndrome (also known as Opitz G/BBB syndrome, Opitz syndrome, or hypertelorism-hypospadias syndrome) is a genetic condition characterized by midline developmental defects affecting multiple organ systems. The name derives from the original descriptions of two conditions — the G syndrome and the BBB syndrome — which were later recognized as the same disorder. The condition exists in two genetic forms: an X-linked form (type I, caused by mutations in the MID1 gene on chromosome Xp22) and an autosomal dominant form (type II, associated with a 22q11.2 deletion involving the SPECC1L gene region). The hallmark features include ocular hypertelorism (widely spaced eyes) and hypospadias in males. Other common midline defects include cleft lip and/or palate, laryngotracheoesophageal (LTE) abnormalities such as laryngeal cleft or tracheoesophageal fistula, congenital heart defects (particularly atrial and ventricular septal defects), and imperforate anus. Swallowing difficulties and aspiration problems related to LTE defects can be life-threatening in the neonatal period. Intellectual disability of variable severity is present in some individuals, more commonly in the X-linked form. Additional features may include midline brain anomalies such as agenesis of the corpus callosum and Dandy-Walker malformation. There is no cure for Opitz GBBB syndrome, and management is symptom-based and multidisciplinary. Surgical correction may be required for hypospadias, cleft lip/palate, congenital heart defects, and tracheoesophageal abnormalities. Speech therapy, developmental support, and regular monitoring of growth and development are important components of care. Early identification of airway and swallowing difficulties is critical to prevent aspiration pneumonia and other complications. Genetic counseling is recommended for affected families to clarify the inheritance pattern and recurrence risk.

Also known as:

Clinical phenotype terms— hover any for plain English:

Widow's peakHP:0000349Laryngeal cleftHP:0008751
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Opitz GBBB syndrome.

View clinical trials →

No actively recruiting trials found for Opitz GBBB syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Opitz GBBB syndrome community →

Specialists

3 foundView all specialists →
EM
Ellen R Elias, MD
AURORA, CO
Specialist
PI on 2 active trials
KM
Kristen Bzdek, MD
Specialist
PI on 1 active trial
RM
Robert Steiner, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Opitz GBBB syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Opitz GBBB syndromeForum →

No community posts yet. Be the first to share your experience with Opitz GBBB syndrome.

Start the conversation →

Latest news about Opitz GBBB syndrome

No recent news articles for Opitz GBBB syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Opitz GBBB syndrome

What is Opitz GBBB syndrome?

Opitz GBBB syndrome (also known as Opitz G/BBB syndrome, Opitz syndrome, or hypertelorism-hypospadias syndrome) is a genetic condition characterized by midline developmental defects affecting multiple organ systems. The name derives from the original descriptions of two conditions — the G syndrome and the BBB syndrome — which were later recognized as the same disorder. The condition exists in two genetic forms: an X-linked form (type I, caused by mutations in the MID1 gene on chromosome Xp22) and an autosomal dominant form (type II, associated with a 22q11.2 deletion involving the SPECC1L gene

At what age does Opitz GBBB syndrome typically begin?

Typical onset of Opitz GBBB syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Opitz GBBB syndrome?

3 specialists and care centers treating Opitz GBBB syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.